Treatment with taurine attenuates hepatic apoptosis in NZB/W F1 mice fed with a high-cholesterol diet

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 20, 2008, Pages 9685-9691

  Hsu, Tsai Ching ^a   Chiang, Szu Yi ^b   Wu, Jen Huang ^a   Tsai, Chun Chou ^a   Huang, Chih Yang ^c,d   Chen, Yi Chen ^a   Tzang, Bor Show ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b Hualien Hospital   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cholesterol; Liver; Systemic lupus erythematosus (SLE); Taurine

Indexed keywords

TAURINE;

ANIMAL; APOPTOSIS; ARTICLE; CHOLESTEROL INTAKE; DRUG EFFECT; FEMALE; HUMAN; LIVER; LIVER CELL; METABOLISM; MITOCHONDRION; MOUSE; NEW ZEALAND BLACK MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; APOPTOSIS; CHOLESTEROL, DIETARY; FEMALE; HEPATOCYTES; HUMANS; LIVER; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED NZB; MITOCHONDRIA; SIGNAL TRANSDUCTION; TAURINE;

MUS;

EID: 55549107536     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf8020255     Document Type: Article

References (46)

1. Xu, H.; Barnes, G. T.; Yang, Q.; Tan, G.; Yang, D.; Chou, C. J.; Sole, J.; Nichols, A.; Ross, J. S.; Tartaglia, L. A.; Chen, H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112, 1821-1830.
2. Kim, S.; Sohn, I.; Ahn, J. I.; Lee, K. H.; Lee, Y. S.; Lee, Y. S. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 2004, 340, 99-109.
3. Carmiel-Haggai, M.; Cederbaum, A. I.; Nieto, N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J. 2005, 19, 136-138.
4. Milagro, F. I.; Campión, J.; Martínez, J. A. Weight gain induced by high-fat feeding involves increased liver oxidative stress. Obesity 2006, 14, 1118-1123.
5. Kleemann, R.; Verschuren, L.; van Erk, M. J.; Nikolsky, Y. O.; Cnubben, N. H.; Verheij, E. R.; Smilde, A. K.; Hendriks, H. F.; Zadelaar, S.; Smith, G. J.; Kaznacheev, V.; Nikolskaya, T.; Melnikov, A.; Hurt-Camejo, E.; van der Greef, J.; van Ommen, B.; Kooistra, T. Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol. 2007, 8, R200.
6. Otogawa, K.; Kinoshita, K.; Fujii, H.; Sakabe, M.; Shiga, R.; Nakatani, K.; Ikeda, K.; Nakajima, Y.; Ikura, Y.; Ueda, M.; Arakawa, T.; Hato, F.; Kawada, N. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: Implications for the pathogenesis of human nonalcoholic steatohepatitis. Am. J. Pathol. 2007, 170, 967-980.
7. Mukai, M.; Bohgaki, T.; Notoya, A.; Kohno, M.; Tateno, M.; Kobayashi, S. Liver dysfunction due to apoptosis in a patient with systemic lupus erythematosus. Lupus 2000, 9, 74-77.
8. Hsu, T. C.; Huang, C. Y.; Chiang, S. Y.; Lai, W. X.; Tsai, C. H.; Tzang, B. S. Transglutaminase inhibitor cystamine alleviates the abnormality in liver from NZB/W F1 mice. Eur. J. Pharmacol. 2008, 579, 382-389.
9. Abraham, S.; Begum, S.; Isenberg, D. Hepatic manifestations of autoimmune rheumatic diseases. Ann. Rheum. Dis. 2004, 63, 123-129.
10. Chung, C. P.; Oeser, A.; Solus, J.; Avalos, I.; Gebretsadik, T.; Shintani, A.; Linton, M. F.; Fazio, S.; Stein, C. M. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus. J. Rheumatol. 2007, 34, 1849-1854.
11. Hahn, B. H. An overview of the pathogenesis of systemic lupus erythematosus. In Dubois' Lupus Erythematosus; Wallace, D. J., Hahn, B. H., Eds.; Williams and Wilkins: Philadelphia, 1993; pp 69-76.
12. Gaipl, U. S.; Kuhn, A.; Sheriff, A.; Munoz, L. E.; Franz, S.; Voll, R. E.; Kalden, J. R.; Herrmann, M. Clearance of apoptotic cells in human SLE. Curr. Dir. Autoimmun. 2006, 9, 173-187.
13. Mackay, I. R.; Taft, L. I.; Cwoling, D. C. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet 1959, 1, 65-69.
14. Runyon, B. A.; LaBrecque, D. R.; Anuras, S. The spectrum of liver disease in systemic lupus erythematosus report of 33 histologically-proved cases and review of the literature. Am. J. Med. 1980, 69, 187-194.
15. Tzang, B. S.; Chiang, S. Y.; Lai, W. X.; Tsai, C. C.; Wu, J. H.; Hsu, T. C. Treatment with cystamine reduces apoptosis in liver from NZB/W F1 mice. Int. Immunopharmacol. 2008, 8, 589-596.
16. Amasaki, Y.; Kobayashi, S.; Takeda, T.; Ogura, N.; Jodo, S.; Nakabayashi, T.; Tsutsumi, A.; Fujisaku, A.; Koike, T. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): A possible mechanism for lymphopenia. Clin. Exp. Immunol. 1995, 99, 245-250.
17. Louzir, B.; Ben Abdelhafidh, N.; Bahri, M.; M'Sadek, F.; Ksontini, I.; Boussema, E.; Othmani, S. Association of systemic lupus erythematosis and myasthenia gravis. A new case report. Tunis. Med. 2003, 81, 963-966.
18. Chesney, R. W. Taurine: Its biological role and clinical implications. Adv. Pediatr. 1985, 32, 1-42.
19. Huxtable, R. J. Physiological actions of taurine. Physiol. Rev. 1992, 72, 101-163.
20. Redmond, H. P.; Wang, J. H.; Bouchier-Hayes, D. Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury. Arch. Surg. 1996, 131, 1280-1287.
21. Kontny, E.; Szczepanska, K.; Kowalczewski, J.; Kurowska, M.; Janicka, I.; Marcinkiewicz, J.; Maslinski, W. The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum. 2000, 43, 2169-2177.
22. Grimble, R. F. Sulphur amino acids and the metabolic response to cytokines. Adv. Exp. Med. Biol. 1994, 359, 41-49.
23. Huxtable, R. J. Taurine past, present, and future. Adv. Exp. Med. Biol. 1996, 403, 641-650.
24. Chorazy, M.; Kontny, E.; Marcinkiewicz, J.; Maslinski, W. Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells. Amino Acids 2002, 23, 407-413.
25. Hagar, H. H.; El Etter, E.; Arafa, M. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Clin. Exp. Pharmacol. Physiol. 2006, 33, 189-196.
26. Saad, S. Y.; Al-Rikabi, A. C. Protection effects of taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy 2002, 48, 42-48.
27. Racasan, S.; Braam, B.; van der Giezen, D. M.; Goldschmeding, R.; Boer, P.; Koomans, H. A.; Joles, J. A. Perinatal l-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats. Hypertension 2004, 44, 83-88.
28. Takatani, T.; Takahashi, K.; Uozumi, Y.; Shikata, E.; Yamamoto, Y.; Ito, T.; Matsuda, T.; Schaffer, S. W.; Fujio, Y.; Azuma, J. Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome. Am. J. Physiol. Cell. Physiol. 2004, 287, C949-C953.
29. Cetiner, M.; Sener, G.; Sehirli, A. O.; Ekşioǧlu-Demiralp, E.; Ercan, F.; Sirvanci, S.; Gedik, N.; Akpulat, S.; Tecimer, T.; Yeǧen, B. C. Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death. Toxicol. Appl. Pharmacol. 2005, 209, 39-50.
30. Karpuj, M. V.; Becher, M. W.; Springer, J. E.; Chabas, D.; Youssef, S.; Pedotti, R.; Mitchell, D.; Steinman, L. Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat. Med. 2002, 8, 143-149.
31. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-684.
32. Wang, X. Z.; Zhang, S. J.; Chen, Y. X.; Chen, Z. X.; Huang, Y. H.; Zhang, L. J. Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro. World J. Gastroenterol. 2004, 10, 2706-2710.
33. Zhang, L. J.; Zheng, W. D.; Shi, M. N.; Wang, X. Z. Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic rat liver. World J. Gastroenterol. 2006, 12, 1918-1923.
34. Shen, Y.; White, E. p53-dependent apoptosis pathways. Adv. Cancer Res. 2001, 82, 55-84.
35. Al-Maini, M. H.; Mountz, J. D.; Al-Mohri, H. A.; El-Ageb, E. M.; Al-Riyami, B. M.; Svenson, K. L.; Zhou, T.; Richens, E. R. Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus. Lupus 2000, 9, 132-9.
36. Gautier, E. L.; Huby, T.; Ouzilleau, B.; Doucet, C.; Saint-Charles, F.; Gremy, G.; Chapman, M. J.; Lesnik, P. Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice. Arterioscler., Thromb., Vasc. Biol. 2007, 27, 1625-1631.
37. Kendler, B. S. Taurine: An overview of its role in preventive medicine. Prev. Med. 1989, 18, 79-100.
38. Hagar, H. H. The protective effect of taurine against cyclosporine-A induced oxidative stress and hepatotoxicity in rats. Toxicol. Lett. 2004, 151, 335-343.
39. Graf, D.; Kurz, A. K.; Reinehr, R.; Fischer, R.; Kircheis, G.; Häussinger, D. Prevention of bile acid-induced apoptosis by betaine in rat liver. Hepatology 2002, 36, 829-839.
40. Schoemaker, M. H.; Conde de la Rosa, L.; Buist-Homan, M.; Vrenken, T. E.; Havinga, R.; Poelstra, K.; Haisma, H. J.; Jansen, P. L.; Moshage, H. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 2004, 39, 1563-1573.
41. Song, G.; Ouyang, G.; Bao, S. The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 2005, 9, 59-71.
42. Dent, P.; Fang, Y.; Gupta, S.; Studer, E.; Mitchell, C.; Spiegel, S.; Hylemon, P. B. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes. Hepatology 2005, 42, 1291-1299.
43. Deldicque, L.; Theisen, D.; Bertrand, L.; Hespel, P.; Hue, L.; Francaux, M. Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways. Am. J. Physiol. Cell. Physiol. 2007, 293, C1263-C1271.
44. Raufman, J. P.; Shant, J.; Guo, C. Y.; Roy, S.; Cheng, K. Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling. J. Cell. Physiol. 2008, 215, 538-549.
45. Xu, Y. J.; Saini, H. K.; Zhang, M.; Elimban, V.; Dhalla, N. S. MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine. Cardiovasc. Res. 2006, 72, 163-174.
46. Feuerstein, G. Z.; Young, P. R. Apoptosis in cardiac diseases: Stress- and mitogen-activated signaling pathways. Cardiovasc. Res. 2000, 45, 560-569.